These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16885850)

  • 21. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of genes involved in melanoma.
    Hinshaw M
    Arch Dermatol; 2006 Apr; 142(4):512-3. PubMed ID: 16618874
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Expression Profiling in Cutaneous Melanoma: Caveats for Clinicians.
    Sominidi-Damodaran S; Pittelkow MR; Meves A
    Mayo Clin Proc; 2016 Aug; 91(8):1147-8. PubMed ID: 27492918
    [No Abstract]   [Full Text] [Related]  

  • 25. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells.
    Liu S; Howell PM; Riker AI
    Ann Surg Oncol; 2013 May; 20(5):1745-52. PubMed ID: 22752337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel genes associated with malignant melanoma but not benign melanocytic lesions.
    Talantov D; Mazumder A; Yu JX; Briggs T; Jiang Y; Backus J; Atkins D; Wang Y
    Clin Cancer Res; 2005 Oct; 11(20):7234-42. PubMed ID: 16243793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
    Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
    BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
    Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
    Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.
    Kunz M; Koczan D; Ibrahim SM; Gillitzer R; Gross G; Thiesen HJ
    Acta Derm Venereol; 2002; 82(3):163-9. PubMed ID: 12353704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting.
    Becker B; Roesch A; Hafner C; Stolz W; Dugas M; Landthaler M; Vogt T
    J Invest Dermatol; 2004 Feb; 122(2):361-8. PubMed ID: 15009717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of tissue microarray for the immunohistochemical profiling of melanoma.
    Pacifico MD; Grover R; Richman P; Daley F; Wilson GD
    Melanoma Res; 2004 Feb; 14(1):39-42. PubMed ID: 15091192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis of melanoma-have we arrived?
    Bordelon JR; Grichnik JM
    Dermatol Ther; 2015; 28(6):405. PubMed ID: 26031627
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
    Gerami P; Alsobrook JP; Palmer TJ; Robin HS
    J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR in melanoma: clinical significance and potential therapeutic target.
    Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
    J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
    Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
    Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma.
    Straume O; Akslen LA
    Br J Cancer; 2005 Oct; 93(8):933-8. PubMed ID: 16189525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.